Company intelligence / Profile preview

NEN Life Sciences

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

NEN Life Science Products was a leading global provider of research products, services, and technologies in areas such as functional genomics, high throughput screening, and drug discovery, supporting advances in target identification and assay development for life sciences and pharmaceutical research before its acquisition by PerkinElmer in 2000[3][2].

Industry: Drug Discovery Services

Beyond the preview

Go deeper on NEN Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NEN Life Sciences.

Explore the full profile